Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Neurocrine Bioscience buy Citigroup Inc.

Neurocrine Bioscience
Start price
€144.65
31.07.26 / 50%
Target price
€216.33
31.07.27
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 31.07.27. The prediction end date can be changed by Citigroup_Inc_ at any time.
Performance without dividends (%)
Name 1w
Neurocrine Bioscience -
iShares Core DAX® 2,59 %
iShares Nasdaq 100 -0,91 %
iShares Nikkei 225® 0,15 %
iShares S&P 500 -0,37 %

Comments by Citigroup_Inc_ for this prediction

In the thread Neurocrine Bioscience diskutieren
Prediction Buy
Perf. (%) -
Target price 216.331
Change
Ends at 31.07.27

Neurocrine Biosciences (NBIX) had its price target raised by Citigroup Inc. from $246.00 to $249.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat

Citigroup Inc. 
0
Report Share
31.07.26

Stopped prediction by Citigroup_Inc_ for Neurocrine Bioscience

buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€123.15
06.05.26
€209.89
06.05.27
17.46%
31.07.26

Citigroup Inc. 
06.05.26 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€112.90
07.04.26
€209.89
07.04.27
28.12%
31.07.26

Citigroup Inc. 
07.04.26 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€103.35
12.02.26
€171.73
12.02.27
39.96%
31.07.26

Citigroup Inc. 
12.02.26 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€117.75
29.10.25
€174.28
29.10.26
22.85%
31.07.26

Citigroup Inc. 
29.10.25 50%